An initiative that aims to position Singapore at the forefront of advancements in RNA science and applications was officially launched on the 24th March 2025.
In August 2024, stakeholders were introduced to the initiative via several engagement sessions.
The National Initiative for RNA Biology & its Applications (NIRBA) is Singapore’s strategic national effort to build globally leading capabilities in RNA biology, driving innovation and applications that address critical health challenges. Supported by the National Research Foundation (NRF) and partner institutions, National University of Singapore (NUS), Nanyang Technological University (NTU), and Agency for Science, Technology and Research (A*STAR), NIRBA is poised to transform Singapore into a global hub for RNA research and its wide-ranging applications to further our understanding of RNA biology, create advancements in research and innovative applications.
Executive Director
National Initiative for RNA Biology & its Applications (NIRBA)
Welcome to NIRBA!
NIRBA is a pioneering national program dedicated to advancing RNA biology research. Established with support from the National Research Foundation (NRF) under the Prime Minister’s Office, Singapore, we unite experts across multiple disciplines to address critical challenges in RNA science and its applications. In collaboration with Singapore’s leading research institutions — the National University of Singapore (NUS), Nanyang Technological University (NTU), and the Agency for Science, Technology and Research (A*STAR) — NIRBA underscores Singapore’s commitment to cutting-edge research with tangible benefits for human health and the bioeconomy. Our goal is to position Singapore as a global leader in RNA biology research.
The establishment of NIRBA comes at a transformative moment in RNA biology, a field that has rapidly emerged as one of the most dynamic and impactful in modern science. From revolutionising vaccine technology during the COVID-19 pandemic to enabling novel treatments for previously untreatable diseases, RNA-based innovations are reshaping medicine and biotechnology. Beyond vaccines, RNA biology holds immense potential for breakthroughs in disease treatment, personalised medicine, food security, and sustainable biotechnology. However, realising these advances depends on a deep and fundamental understanding of RNA biology. NIRBA is committed to bridging scientific gaps and leveraging Singapore’s strengths — particularly its unique focus on the genetic diversity of Asian populations — to enhance healthcare, improve lives, and strengthen economic resilience.
To create differentiated, globally competitive peaks of excellence for research on RNA Biology & its Applications, poised to fuel downstream translation and health impact.
To drive excellence in targeted RNA research and develop innovative solutions that address critical challenges, enhance quality of life, and promote sustainable progress through a vibrant and collaborative research ecosystem.
NIRBA is a collaborative effort involving multiple stakeholders in Singapore. Together, we are building a robust ecosystem that supports RNA research from the lab to clinical and commercial applications.
